• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Platelets as a marker of adrenergic and serotonergic receptors in dogs

Research Project

Project/Area Number 11660313
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Applied veterinary science
Research InstitutionTottori University

Principal Investigator

HIKASA Yoshiaki  Tottori University, Faculty of Agriculture, Professor, 農学部, 教授 (30165071)

Co-Investigator(Kenkyū-buntansha) SATO Kota  Tottori University, Faculty of Agriculture, Assistant Professor, 農学部, 講師 (50283974)
Project Period (FY) 1999 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2001: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 2000: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1999: ¥1,900,000 (Direct Cost: ¥1,900,000)
KeywordsDog / Platelet / Adrenoceptor / Imidazoline receptor / Guanine nucleotide / Adrenaline / Serotonin / GTP binding protein / イダゾキサン / クロニジン / ヨヒンビン / アグマチン / 血小板凝集
Research Abstract

The present study was conducted to investigate the platelet activity as a marker of adrenergic, non-adrenergic, and serotonergic receptors in dogs, based on previous findings that monoamine, and in particular 5-hydroxytryptamine in the brain, are involved in the regulation of α_2-adrenoceptor-mediated emesis. This study demonstrated that the α_<2A>-adrenoceptor subtype exists on canine platelets, and this type of receptors was involved in the mediation of adrenaline-potentiated platelet aggregation. The results of α_2-adrenoceptor binding and the α_2-adrenoceptor-mediated cardiovascular effects during canine endotoxin shock revealed that significant positive correlations were observed for reduced number of α_2-adrenoceptors between platelets and brain, and diminished cardiovascular effects of α_2-adrenoceptor agonists. Therefore, the α_<2A>-adrenoceptor activity was impaired in the central nervous system as well as in the peripheral vascular system during canine endotoxin shock. These results indicated that platelets may in part represent a good model which reflects the α_2-adrenoceptor changes in the central nervous system and peripheral vascular system during and after activation of sympatho-adrenal nerve activity. On the other hand, this study demonstrated that imidazol(in)e (I) structure has a role for inhibition of adrenaline-potentiated platelet aggregation in dogs, and that two subtypes of non-adrenergic I receptors, I_1 and I_2, exist on canine platelets. In addition, this study suggested that I_1 subtype was coupled with GTP-binding proteins, and I_2 was not coupled with those. Further studies may be required to investigate the function of I_1 and I_2 receptors as well as 5-HT receptors in canine platelets.

Report

(4 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • 1999 Annual Research Report
  • Research Products

    (18 results)

All Other

All Publications (18 results)

  • [Publications] Yoshiaki Hikasa: "Alpha adrenoceptor subtypes involved in the emetic action in dogs"Journal of Pharmacology and Experimental Therapeutics. 261・2. 746-754 (1992)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yoshiaki Hikasa: "Central alpha-adrenoceptor subtypes involved in the emetic pathway in cats"European Journal of Pharmacology. 229・2-3. 241-251 (1992)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yoshiaki Hikasa: "Platelet and brain α_2-adrenoceptors and cardiovascular sensitivity to agonists in dogs suffering from endotoxic shock"Fundamental and Clinical Pharmacology. 12・5. 498-509 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yoshiaki Hikasa: "Effects of imidazoline and non-imidazoline α-adrenergic agents on canine platelet aggregation"Pharmacology. 58・4. 171-182 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tamas Ambrisko: "Neurohormonal and metabolic effects of medetomidine compared with xylazine in beagle dogs"Canadian Journal of Veterinary Research. 66・1. 42-49 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Kazuhito Itamoto: "Quantitative electroencephalography of medetomidine, medetomidine-midazolam and medetomidine-midazolam-butorphanol in dogs"Journal of Veterinary Medicine, Series A. (in press). (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yoshiaki Hikasa, et al: "Alpha adrenoceptor subtypes involved in the emetic action in dogs"Journal of Pharmacology and Experimental Therapeutics. 261 (2). 746-754 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yoshiaki Hikasa, et al: "Central alpha-adrenoceptor subtypes involved in the emetic pathway in cats"European Journal of Pharmacology. 229 (2-3). 241-251 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yoshiaki Hikasa, et al: "Platelet and brain α_2-adrenoceptors and cardiovascular sensitivity to agonists in dogs suffering from endotoxic shock"Fundamental and Clinical Pharmacology. 12 (5). 498-509 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yoshiaki Hikasa, et al: "Effects of imidazoline and non-imidazoline α-adrenergic agents on canine platelet aggregation"Pharmacology. 58 (4). 171-182 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tamas Ambrisko and Yoshiaki Hikasa: "Neurohormonal and metabolic effects of medetomidine compared with xylazine in beagle dogs"Canadian Journal of Veterinary Research. 66 (1). 42-49 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Kazuhito Itamoto, et al: "Quantitative electroencephalography of medetomidine, medetomidine-midazolam and medetomidine-midazolam-butorphanol in dogs"Journal of Veterinary Medicine. Series A, (in press). (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yoshiaki Hikasa et al.: "Connective tissue-type mast cell leukemia in a dog"Journal of Veterinary Medical Science. 62・2. 187-190 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Tamas Ambrisko et al.: "Neurohormonal and metabolic effects of medetomidine compared with xylazine in beagle dogs"Canadian Journal of Veterinary Research. 66・1. 42-49 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Kazuhito Itamoto et al.: "Quantitative electroencephalography of medetomidine, medetomidine-midazolam and medetomidine-midazolam-butorphanol in dogs"Journal of Veterinary Medicine, Series A. 49(in press). (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yoshiaki Hikasa, et al: "Effects of imidazoline and non-imidazoline a-adrenergic agents on canine platelet aggregation"Pharmacology. 58・4. 171-182 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yoshiaki Hikasa, et al: "Anaesthetic and cardiopulmonary effects of balanced anaesthesia with medetomidine-midazolam and butorphanol in dogs"Journal of Veterinary Medicine, Series A. 47・7. 411-420 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yoshiaki Hikasa: "Effects of imidazoline and non-imidazoline α-adrenergic agents on canine platelet aggregation"Pharmacology. 58・4. 171-182 (1999)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi